A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distr... by Morris Peter E, Steingrub Jay S, Huang Bee Y, Tang Shamay, Liu Patrick M, Rhode Peter R, Wong Hing C

Get full text

Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery by Tang, Li, Zheng, Yiran, Melo, Mariane Bandeira, Mabardi, Llian, Castaño, Ana P, Xie, Yu-Qing, Li, Na, Kudchodkar, Sagar B, Wong, Hing C, Jeng, Emily K, Maus, Marcela V, Irvine, Darrell J

Get full text
Get full text
Get full text

A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4⁺ T-Cells to Recognition by Cytotoxic T-Lymphocytes by O’Connor, Rachel, Rimpel, Katherine, Sloan, Derek D., Karel, Dan, Wong, Hing C., Jeng, Emily K., Thomas, Allison S., Whitney, James B., Lim, So-Yon, Kovacs, Colin, Benko, Erika, Karandish, Sara, Huang, Szu-Han, Buzon, Maria J., Lichterfeld, Mathias, Irrinki, Alivelu, Murry, Jeffrey P., Tsai, Angela, Yu, Helen, Geleziunas, Romas, Trocha, Alicja, Ostrowski, Mario A., Walker, Bruce D., Jones, Richard Bradley, Mueller, Stefanie, Irvine, Darrell J

Get full text
Get full text